CA-A Cancer Journal for Clinicians

Papers
(The median citation count of CA-A Cancer Journal for Clinicians is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries51023
Cancer Statistics, 202111276
Cancer statistics, 20229749
Cancer statistics, 20234567
Management of glioblastoma: State of the art and future directions918
Cancer treatment and survivorship statistics, 2022887
Current treatment and recent progress in gastric cancer747
Breast Cancer Statistics, 2022613
Cancer statistics for adolescents and young adults, 2020565
Treatment of muscle‐invasive and advanced bladder cancer in 2020482
Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society451
Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries448
Colorectal cancer statistics, 2023410
Brain and other central nervous system tumor statistics, 2021400
Outdoor air pollution and cancer: An overview of the current evidence and public health recommendations339
American Cancer Society guideline for diet and physical activity for cancer prevention337
Soft‐tissue sarcoma in adults: An update on the current state of histiotype‐specific management in an era of personalized medicine264
Metabolomics in cancer research and emerging applications in clinical oncology264
Cancer statistics for African American/Black People 2022228
Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma227
American Cancer Society nutrition and physical activity guideline for cancer survivors227
Older adult participation in cancer clinical trials: A systematic review of barriers and interventions218
Cancer statistics for the US Hispanic/Latino population, 2021171
Clinical management of metastatic colorectal cancer in the era of precision medicine164
147
Integrative oncology: Addressing the global challenges of cancer prevention and treatment140
Radiation therapy‐associated toxicity: Etiology, management, and prevention132
Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies126
A systematic review of rehabilitation and exercise recommendations in oncology guidelines111
Molecular imaging in oncology: Current impact and future directions108
American Cancer Society's report on the status of cancer disparities in the United States, 202198
Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions97
Human papillomavirus vaccination 2020 guideline update: American Cancer Society guideline adaptation91
An update on the immune landscape in lung and head and neck cancers86
85
Innovations in research and clinical care using patient‐generated health data81
Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians79
Onconephrology: The intersections between the kidney and cancer75
Intermittent fasting in the prevention and treatment of cancer73
Evolving standards of care and new challenges in the management of HER2‐positive breast cancer73
Navigating financial toxicity in patients with cancer: A multidisciplinary management approach72
72
Cervical cancer prevention and control in women living with human immunodeficiency virus67
Mailed fecal immunochemical test outreach for colorectal cancer screening: Summary of a Centers for Disease Control and Prevention–sponsored Summit67
Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward67
Cancer statistics, 202463
The new (Version 9) American Joint Committee on Cancer tumor, node, metastasis staging for cervical cancer61
Racial and socioeconomic disparities in lung cancer screening in the United States: A systematic review59
The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies59
Blueprint for cancer research: Critical gaps and opportunities47
Climate change and cancer45
Cancer epigenetics in clinical practice43
Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians42
Recent progress in the treatment of cancer in children42
40
Sexual health among adolescent and young adult cancer survivors: A scoping review from the Children's Oncology Group Adolescent and Young Adult Oncology Discipline Committee39
An overview of real‐world data sources for oncology and considerations for research38
Cancer statistics forAmericanIndian andAlaskaNative individuals, 2022: Including increasing disparities in early onset colorectal cancer38
The contemporary management of cancers of the sinonasal tract in adults35
Current and future cancer staging after neoadjuvant treatment for solid tumors35
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions31
Critical care management of chimeric antigen receptor T‐cell therapy recipients29
Addressing distress management challenges: Recommendations from the consensus panel of the American Psychosocial Oncology Society and the Association of Oncology Social Work26
Cardio‐oncology care in the era of the coronavirus disease 2019 (COVID‐19) pandemic: An International Cardio‐Oncology Society (ICOS) statement26
Erratum to “Cancer statistics, 2021”25
Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice25
25
Patient navigation across the cancer care continuum: An overview of systematic reviews and emerging literature24
Time to add screening for financial hardship as a quality measure?24
Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer23
The contemporary management of peritoneal metastasis: A journey from the cold past of treatment futility to a warm present and a bright future22
20
How can hospitals change practice to better implement smoking cessation interventions? A systematic review19
Oncologic emergencies and urgencies: A comprehensive review18
Health insurance status and cancer stage at diagnosis and survival in the United States18
Radiotheranostics in oncology: Making precision medicine possible17
Hematology and oncology clinical care during the coronavirus disease 2019 pandemic16
Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus‐associated oropharyngeal cancer16
Screening for lung cancer: 2023 guideline update from the American Cancer Society15
An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma14
Genetic testing in prostate cancer management: Considerations informing primary care14
13
Locally advanced rectal adenocarcinoma: Treatment sequences, intensification, and rectal organ preservation12
12
Examining the interrelationships between mindfulness‐based interventions, depression, inflammation, and cancer survival12
12
Clinician communication strategies associated with increased uptake of the human papillomavirus (HPV) vaccine: A systematic review12
Breast cancer recurrence risk can remain for 10 to 32 years10
Interventional gastroenterology in oncology9
Current treatment and future directions in the management of anal cancer9
Nutrition and Physical Activity Guideline for Cancer Survivors9
Multidisciplinary considerations in the treatment of triple‐negative breast cancer8
Planning for post‐pandemic cancer care delivery: Recovery or opportunity for redesign?8
Cancer risk among World Trade Center rescue and recovery workers: A review8
Social determinants of health and US cancer screening interventions: A systematic review7
The social media cancer misinformation conundrum7
Female erectile tissues and sexual dysfunction after pelvic radiotherapy: A scoping review7
Rates of advanced prostate cancer continue to increase7
7
Cancer treatment delays caused by the COVID‐19 pandemic may not hinder outcomes6
Multidisciplinary considerations in the maintenance treatment of poly(ADP‐ribose) polymerase inhibitors for homologous recombination‐proficient, advanced‐stage epithelial ovarian cancer6
Screening for cervical cancer6
Acquiring tissue for advanced lung cancer diagnosis and comprehensive biomarker testing: A National Lung Cancer Roundtable best‐practice guide6
Pairing smoking cessation with lung cancer screening may save lives6
Translating energy balance research from the bench to the clinic to the community: Parallel animal‐human studies in cancer6
Fecal microbiota transplants may aid melanoma immunotherapy resistance6
Survival outcomes used to validate version 9 of the American Joint Committee on Cancer staging system for appendiceal cancer6
Opportunistic salpingectomy may reduce ovarian cancer risk5
Modern developments in germline pharmacogenomics for oncology prescribing5
Medicaid expansion increases survival for patients with cancer5
4
American Cancer Society’s report on the status of cancer disparities in the United States, 20234
4
Cancer care for people with dementia: Literature overview and recommendations for practice and research4
The case for catch‐up human papillomavirus vaccination in at‐risk populations: Rural communities and survivors of pediatric and young adult cancers4
4
Locally advanced lung cancer4
Survival outcomes used to generate version 9 American Joint Committee on Cancer staging system for anal cancer4
It's not a mystery, it's in the history: Multidisciplinary management of multiple endocrine neoplasia type 14
4
0.022139072418213